Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06551220

Recruiting

Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns (HEROIC)

Metastatic Breast Cancer
NCT06459791

Recruiting

Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR) (AVATAR)

Metastatic Breast Cancer
NCT06409390

Recruiting

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

Metastatic Breast Cancer
NCT06383767

Recruiting

A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer

Metastatic Breast Cancer
NCT06354114

Not yet recruiting

A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011

Advanced Breast Cancer
NCT06343181

Recruiting

A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT06339281

Not yet recruiting

A Multicenter Clinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast Cancer

Advanced Breast Cancer
NCT06334354

Recruiting

A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC) (TRAC)

Breast Cancer Survivors
NCT06332976

Recruiting

PrefeRences And ChemoTherapy In Breast Cancer patiEnts (PRACTICE)

Female Breast Cancer
NCT06195618

Not yet recruiting

Personalized Vaccine for TNBC Immunotherapy (TEBICA003 TNBC)

Breast Cancer Female
NCT06105749

Recruiting

Biennial CEM in Women With a Personal History of Breast Cancer

Neoplasms | Breast Cancer | Breast Neoplasms | Breast Cancer Female
NCT06105684

Recruiting

Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer

Metastatic Breast Cancer
NCT06045572

Not yet recruiting

Vascular Supply Identification, Lesion Extension and Search for Tumor Similarity at a Distance by VTM in Breast Cancer

Breast Cancer Female
NCT06035679

Recruiting

Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer

Breast Cancer Female
NCT06023277

Not yet recruiting

A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer

Metastatic Breast Cancer
NCT05894239

Recruiting

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer (INAVO122)

Metastatic Breast Cancer
NCT05876065

Recruiting

Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer

Advanced Breast Cancer
NCT05831878

Recruiting

RC48-ADC in HER2-low Advanced Breast Cancer

Advanced Breast Cancer
NCT05767931

Not yet recruiting

Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer

Invasive Breast Cancer
NCT05760183

Not yet recruiting

Discovering Factors in Metastatic Breast Cancer Patients' Clinical Trial Experiences

Metastatic Breast Cancer
NCT05699577

Not yet recruiting

Prognostic Value of Some Biochemical Markers in Breast Cancer

Breast Cancer Female
NCT05696626

Recruiting

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation (ELAINEIII)

Metastatic Breast Cancer
NCT05652569

Recruiting

CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer (CATCH)

Metastatic Breast Cancer
NCT05563220

Recruiting

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer (ELEVATE)

Breast Cancer | Metastatic Breast Cancer
NCT05536128

Recruiting

Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor (Post-CDK)

Advanced Breast Cancer
NCT05370300

Not yet recruiting

SNAPS Breast Cancer Patient Study Breast Cancer Patients

Breast Cancer | Breast Cancer Female
NCT05135104

Recruiting

Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period (PALBO)

Metastatic Breast Cancer
NCT04892693

Recruiting

Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency

Advanced Breast Cancer
NCT04468113

Recruiting

Clip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant Therapy (Ultra3Detect)

Primary Breast Cancer
NCT04263298

Recruiting

Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer

Metastatic Breast Cancer
NCT04247035

Recruiting

Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer
NCT04133077

Recruiting

Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer (XenoBreast)

Breast Cancer Female
NCT04037852

Recruiting

Robotic Versus Conventional or Endoscopic Nipple Sparing Mastectomy in the Management of Breast Cancer-Prospective Study (RCENSM-P)

Breast Cancer Female
NCT03664895

Recruiting

Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)

Breast Cancer Invasive
NCT03342625

Recruiting

High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study (BRIFU)

Breast Cancer Female
NCT02917005

Recruiting

PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer (FATIMA)

Metastatic Breast Cancer
NCT00437879

Recruiting

Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment.

Breast Cancer Invasive
NCT03632941

Terminated

A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer

Breast Cancer | HER2+ Breast Cancer
NCT06710990

Completed

Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer

Advanced Breast Cancer
NCT04248257

Completed

Peer Support For Young Adult Women With High Breast Cancer Risk

Breast Cancer Risk
NCT06018337

Active, not recruiting

A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

Metastatic Breast Cancer
NCT04961996

Active, not recruiting

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

Early Breast Cancer
NCT06441474

Active, not recruiting

Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women

Breast Cancer Female
NCT05596409

Active, not recruiting

ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study (ELCIN)

Metastatic Breast Cancer
NCT03250351

Completed

Nerve Mobilization Techniques After Breast Cancer Surgery (PT-ND-BC)

Breast Cancer Female
NCT02942355

Active, not recruiting

Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer

Breast Cancer | Female Breast Carcinoma
NCT03612648

Completed

Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma

Breast Cancer | Breast Carcinoma
NCT02329639

Completed

Prospective Study of VEGFR-2 /IL-8 Genetic Interaction in MBC Treated With Paclitaxel and Bevacizumab vs. Chemotherapy (BEVAPROS)

Metastatic Breast Cancer
NCT05161195

Active, not recruiting

Roll-over Study to Allow Continued Access to Ribociclib

Metastatic Breast Cancer
NCT06062992

Completed

Contrast-Enhanced Stereotactic Biopsy (CESB)

Breast Cancer | Breast Neoplasms | Breast Cancer Female

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations